Spensus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.20 Cr
as on 23-10-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.98 Cr
as on 23-10-2024
- Revenue 1191.35%
(FY 2023)
- Profit 803.09%
(FY 2023)
- Net Worth 0.24%
(FY 2023)
- Total Assets 211.29%
(FY 2023)
About Spensus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.20 Cr.
The company currently has active open charges totaling ₹17.98 Cr.
Tanmay Patel and Nileshkumar Patel serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC100978
- Company No.
100978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Spensus Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanmay Patel  | Director | 24-Feb-2018 | Current |
| Nileshkumar Patel | Director | 24-Feb-2018 | Current |
Financial Performance of Spensus Pharmaceuticals.
Spensus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1191.35% increase. The company also saw a substantial improvement in profitability, with a 803.09% increase in profit. The company's net worth moved up by a moderate rise of 0.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Spensus Pharmaceuticals?
Unlock access to Spensus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 27 Aug 2024 | ₹3.48 Cr | Open |
Sidbi Creation Date: 13 Jan 2022 | ₹5.00 M | Open |
Sidbi Creation Date: 13 Jan 2022 | ₹9.00 Cr | Open |
How Many Employees Work at Spensus Pharmaceuticals?
Unlock and access historical data on people associated with Spensus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spensus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spensus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
